Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy

Circulation

Volumn 95, Issue 11, 1997, Pages 2476-2478

  McNamara, Dennis M ^a   Rosenblum, Warren D ^b   Janosko, Karen M ^b   Trost, Mary K ^b   Villaneuva, Flordeliza S ^b   Demetris, A J ^b   Murali, Srinivas ^b   Feldman, Arthur M ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

cardiomyopathy; immune globulin; myocarditis

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; MYOCARDITIS; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0030920950     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.11.2476     Document Type: Article

References (19)

1. Heart failure: management of patients with left-ventricular systolic dysfunction. In: Quick Reference Guide for Clinicians No. 11. AHCPR publication 94-0613. Rockville, Md: Agency for Health Policy and Research, Pubic Health Service, US Department of Health and Human Services; June 1994.
2. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction, Circulation. 1990;82:8-16.
3. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO, Alling D, Wittes JT, Ferrans VJ, Rodriguez ER, Fauci AS. A prospective randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989;321:1061-1068.
4. Mason JM, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, and the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis, N Engl J Med. 1995;333:269-275.
5. Drucker MA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, Baker AL, Perez-Atayde AR, Newburger JW. Gammaglobulin treatment of acute myocarditis in the pediatric population. Circulation. 1994;89:252-257.
6. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EGJ, Schoen FJ. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
7. Dec GW, Palacios IF, Fallon JT, Aretz T, Mills J, Lee DC Johnson RA. Active myocarditis in the spectrum of acute dilated cardiormyopathies. N Engl J Med. 1985;312:885-890.
8. Steimle AE, Stevenson LW, Fonarow GC, Hamilton MA, Moriguchi JD. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol. 1994;23:553-559.
9. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol. 1994;23:146-153.
10. Michaels W, Moll PP, Rodeheffer RJ, Miller FA, Tajik AJ, Burnett JC, Driscoll DJ, Thibodeau SN, Ansari AA, Herskowitz A. Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc. 1994;69:24-27.
11. Geha RS. Regulation of the immune response by idiotypic-antiidiotypic interactions. N Engl J Med. 1981;305:25-28.
12. Dietrich G, Kaveri SV, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol. 1992;62:S73-S81.
13. Berchtold P, McMillan R. Intravenous immunoglobulin: new aspects of mechanism of action in chronic ITP. In: Imbach P, ed. Immunotherapy With Intravenous Immunoglobulins. London, UK: Academic Press; 1991:245-252
14. Thornton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol. 1994; 35:260-268.
15. Oates JA, Wood AJ. Manipulating the immune system with immune globulin. N Engl J Med. 1992;326:107-116.
16. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101: 425-483.
17. Tomioka N, Kishimoto C, Matsumori A, Kawai C. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol. 1986;7:868-872.
18. Weiler AH, Hall M, Huber SA. Polyclonal immunoglobulin therapy protects against cardiac damage in experimental coxsackievirus induced myocarditis. Eur Heart J. 1992;13:115-119.
19. Takada H, Kishimoto C, Hiraoka Y. Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model: antiviral and anti-inflammatory effects. Circulation. 1995;92: 1604-1611.